Medifast, Inc. Financial Ratios — MED Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	25.51	19.34	25.34	14.74	23.73	19.32	27.1	51.26	72.84	78.49	91.2	80.31	55.77	1.02	-9.13
Return on Assets (%)	18.57	13.46	18.23	10.61	17.29	15.03	20.75	35.38	42.8	43.7	48.64	40.18	31.76	0.7	-7.02
Return on Capital (%)	23.73	18.23	24.68	14.48	23.36	19.3	27.1	51.26	68.49	71.72	81.32	69.27	49.14	0.93	- -
Return on Invested Capital (%)	23.46	20.01	26.98	21.89	21.96	19.09	26.55	49.89	66.92	70.66	80.3	67.64	46.24	0.68	- -
Gross Margin (%)	75.29	74.05	74.24	73.33	73.8	74.91	75.54	75.83	75.22	74.65	73.89	71.34	72.37	73.8	71.33
EBITDA Margin (%)	11.98	11.15	14.29	13.42	13.12	11.75	14.54	14.67	13.4	14.81	14.62	12.25	13.01	2.59	0.01
Operating Margin (%)	9.18	8.52	11.85	10.6	10.52	9.78	13.14	13.78	12.76	14.35	14.17	11.56	11.79	0.48	-3.68
Incremental Operating Margin (%)	-10.48	-1.19	205.54	21.06	12.48	-103.63	47.26	14.76	10.33	19.5	13.88	-43.36	11.09	26.3	- -
Pretax Margin (%)	9.28	8.9	12.05	11.11	10.88	9.88	13.37	14.08	12.94	14.36	14.16	11.51	12.01	0.63	-1.46
Profit Margin (%)	6.22	4.98	7.4	4.62	7.35	6.5	9.19	11.14	10.92	11	10.75	8.98	9.27	0.35	-4.84
Net Income to Common Margin (%)	6.22	4.98	7.4	4.62	7.35	6.5	9.19	11.14	10.92	11	10.75	8.98	9.27	0.35	-4.84
Effective Tax Rate (%)	33.02	34.96	30.5	33.65	34.05	34.24	31.26	20.92	15.64	23.39	24.11	22	22.81	44.78	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	66.66	55.52	41.51	45.43	51.71	38.93	49.89	73.45	34.19	-1.04
Sustainable Growth Rate (%)	25.51	19.34	25.34	14.74	23.73	6.44	12.05	29.98	39.75	37.9	55.7	40.25	14.81	0.67	-9.23

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	6	4	1	2	- -	- -	- -	- -	14	11	33	26	22	16	11
ST Debt	1	1	- -	2	- -	- -	- -	- -	3	4	7	6	6	6	5
LT Debt	4	4	- -	- -	- -	- -	- -	- -	10	7	26	20	16	10	6
Total Debt/EBITDA	0.16	0.12	0.02	0.06	0.01	- -	- -	- -	0.14	0.08	0.15	0.13	0.16	1.03	368.76
Net Debt/EBITDA	-0.27	-1.02	-0.78	-0.59	-1.17	-1.63	-1.71	-1.11	-0.8	-1.18	-0.47	-0.45	-0.68	-5.83	-3,079.41
Total Debt/EBIT	0.21	0.16	0.02	0.08	0.01	- -	- -	- -	0.15	0.08	0.15	0.14	0.17	5.6	-0.75
Net Debt/EBIT	-0.35	-1.34	-0.94	-0.74	-1.47	-1.95	-1.89	-1.18	-0.85	-1.22	-0.48	-0.47	-0.75	-31.59	6.28
EBITDA to Interest Expense	350.25	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	279.3	- -	- -	- -
EBITDA-CapEx/Interest Expense	206.53	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	255.5	- -	- -	- -
EBIT to Interest Expense	268.45	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	263.63	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	- -	- -	- -
Common Equity/Total Assets	69.47	69.7	74.19	69.43	76.29	79.21	74.41	64.4	53.86	56.96	50.83	49.03	65.01	73.93	80.22
Long-Term Debt/Equity (%)	5.79	4.2	0.48	0.3	- -	- -	- -	- -	9.95	4.76	12.85	13.08	8	4.73	3.06
Long-Term Debt/Capital (%)	5.38	4	0.48	0.29	- -	- -	- -	- -	8.81	4.45	11.07	11.2	7.22	4.4	2.91
Long-Term Debt/Total Assets (%)	4.02	2.92	0.36	0.21	- -	- -	- -	- -	5.36	2.71	6.53	6.41	5.2	3.5	2.46
Total Debt/Equity (%)	7.73	4.78	0.71	3.05	0.25	- -	- -	- -	12.97	7.1	16.07	16.8	10.93	7.67	5.38
Total Debt/Capital (%)	7.18	4.56	0.7	2.96	0.25	- -	- -	- -	11.48	6.63	13.85	14.39	9.85	7.13	5.1
Total Debt/Total Assets (%)	5.37	3.33	0.52	2.12	0.19	- -	- -	- -	6.99	4.04	8.17	8.24	7.1	5.67	4.31
Net Debt to Equity	-12.94	-39.98	-36.74	-27.93	-47.45	-54.61	-69.14	-74.57	-73.43	-104.12	-51.46	-56.56	-46.87	-43.28	-44.89
Net Debt/Capital (%)	-14.66	-65.77	-57.64	-38.44	-89.89	-120.32	-224.08	-293.29	-185.66	-3,495.37	-79.63	-93.88	-73.18	-67.2	-74.23
EBITDA	36	36	46	38	36	32	44	73	96	138	223	196	140	16	- -
EBITDA-CapEx	21	27	35	31	33	29	41	69	86	133	189	179	133	8	-6
Operating Income (Loss)	27	27	38	30	29	27	40	69	91	134	216	185	126	3	-14

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	1.67	2.09	2.5	1.95	2.85	3.15	2.66	1.67	1.17	1.57	0.65	0.62	1.63	2.53	3.89
Current Ratio	3.16	3.08	3.39	3.04	3.69	4.15	3.37	2.41	1.94	2.1	1.81	1.58	2.43	3.34	4.69
Quick Ratio	1.74	2.16	2.54	2.02	2.92	3.2	2.68	1.69	1.19	1.57	0.65	0.62	1.63	2.53	3.89
CFO/Avg Current Liab	1.93	1.64	1.52	0.94	1.16	1.06	1.4	1.25	1.21	1.52	0.67	1.25	1.27	0.31	0.13
Common Equity/Total Assets	69.47	69.7	74.19	69.43	76.29	79.21	74.41	64.4	53.86	56.96	50.83	49.03	65.01	73.93	80.22
Long-Term Debt/Equity (%)	5.79	4.2	0.48	0.3	- -	- -	- -	- -	9.95	4.76	12.85	13.08	8	4.73	3.06
Long-Term Debt/Capital (%)	5.38	4	0.48	0.29	- -	- -	- -	- -	8.81	4.45	11.07	11.2	7.22	4.4	2.91
Long-Term Debt/Total Assets (%)	4.02	2.92	0.36	0.21	- -	- -	- -	- -	5.36	2.71	6.53	6.41	5.2	3.5	2.46
Total Debt/Equity (%)	7.73	4.78	0.71	3.05	0.25	- -	- -	- -	12.97	7.1	16.07	16.8	10.93	7.67	5.38
Total Debt/Capital (%)	7.18	4.56	0.7	2.96	0.25	- -	- -	- -	11.48	6.63	13.85	14.39	9.85	7.13	5.1
Total Debt/Total Assets (%)	5.37	3.33	0.52	2.12	0.19	- -	- -	- -	6.99	4.04	8.17	8.24	7.1	5.67	4.31
CFO/Total Liabilities	108.08	102.02	123.74	72.07	106.82	100.6	115.77	100.82	93.81	122.18	48.27	120.72	136.18	33.03	13.99
CFO/CapEx	2.38	4.95	3.72	3.64	10.43	8.81	13.34	12.31	8.38	24.66	2.76	11.66	22.78	3.28	1.22
Altman's Z-Score	8.98	10.05	11.02	11.7	12.7	16.6	18.11	20.75	15.5	17.98	14.14	12.58	10.16	5.22	4.46

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	283.99	175.76	209.74	220.13	166.17	181.81	307.25	631.38	583.07	925.13	5,226.33	- -	- -	- -	- -
Days Sales Outstanding	1.29	2.08	1.74	1.66	2.2	2.01	1.19	0.58	0.63	0.39	0.07	- -	- -	- -	- -
Inventory Turnover	3.73	4.05	4.36	4.57	4.92	4.35	3.92	4.16	4.03	4.64	3.41	3.07	3.42	3.25	3.53
Days Inventory Outstanding	97.83	90.02	83.81	79.81	74.24	83.86	93.14	87.73	90.48	78.66	106.91	119.06	106.87	112.17	103.38
Accounts Payable Turnover	11.69	5.78	5.68	6.14	5.89	7.09	6.4	8.57	8.97	8.23	9.82	6.4	5.03	4.68	4.64
Accounts Payable Turnover Days	31.21	63.18	64.28	59.48	61.95	51.51	57.06	42.57	40.69	44.33	37.18	57.01	72.64	77.98	78.68
Cash Conversion Cycle	67.9	28.92	21.27	21.99	14.49	34.35	37.27	45.73	50.41	34.72	69.8	62.05	34.23	34.19	24.69
Inventory to Cash Days	-96.54	-87.94	-82.07	-78.16	-72.05	-81.85	-91.95	-87.15	-89.85	-78.27	-106.84	-119.06	-106.87	-112.17	-103.38
Inventories	20	21	18	16	13	18	19	39	49	53	180	119	55	42	20
Raw Materials	5	6	5	4	4	6	4	11	11	13	15	13	8	7	5
Work In Process	2	- -	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	13	15	12	11	9	12	14	28	36	38	169	106	47	36	18
Other Inventory	- -	1	- -	1	1	1	1	2	4	4	4	4	2	1	2

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	213	363	343	405	358	494	836	1,484	1,289	2,311	2,428	1,254	732	193	117
- Cash & Cash Equivalents	14	40	36	24	42	52	75	81	77	164	104	88	94	91	89
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	6	4	1	2	- -	- -	- -	- -	14	11	33	26	22	16	11
Enterprise Value	185	308	276	355	291	417	737	1,383	1,210	2,148	2,351	1,193	604	47	-39
Total Capital	79	95	99	83	89	96	109	109	118	168	235	181	223	226	210
Total Debt/Capital (%)	7.18	4.56	0.7	2.96	0.25	- -	- -	- -	11.48	6.63	13.85	14.39	9.85	7.13	5.1
Total Debt / EV	0.03	0.01	- -	0.01	- -	- -	- -	- -	0.01	0.01	0.01	0.02	0.04	0.35	-0.27
EV/Sales	0.62	0.97	0.85	1.24	1.07	1.52	2.44	2.76	1.7	2.3	1.54	0.75	0.56	0.08	- -
EV/EBITDA	5.17	8.66	5.95	9.27	8.14	12.94	16.81	18.81	12.65	15.51	10.54	6.09	4.33	2.98	- -
EV/EBIT	6.74	11.34	7.18	11.74	10.16	15.54	18.59	20.02	13.29	16.01	10.87	6.45	4.78	16.16	- -
EV/Cash Flow to Firm	5.29	7.64	6.51	13.9	9.91	16.46	17.04	22.74	14.36	14.79	24.87	6.11	4.09	1.9	- -
EV/Free Cash Flow to Firm	3.72	6.36	5.13	10.9	9.04	14.79	15.85	21.03	12.83	14.22	18.26	5.63	3.92	1.46	- -
Diluted Market Cap	195	363	361	429	367	497	844	1,510	1,328	2,327	2,474	1,301	734	193	117
Diluted Enterprise Value	186	327	325	407	325	445	769	1,429	1,264	2,174	2,402	1,239	662	118	39
EV per Share	11.91	22.35	21.01	29.39	24.71	35.16	61.55	116.51	102.86	182.47	202.79	109.68	55.47	4.25	- -
TTM Sales	298	319	324	285	273	275	302	501	714	935	1,526	1,599	1,072	602	386
TTM EBITDA	36	36	46	38	36	32	44	73	96	138	223	196	140	16	- -
TTM Operating Income	27	27	38	30	29	27	40	69	91	134	216	185	126	3	-14
TTM Cash Flow to Firm	35	40	42	26	29	25	43	61	84	145	95	195	148	24	7
TTM Free Cash Flow to Firm	50	48	54	33	32	28	46	66	94	151	129	212	154	32	12

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	3.93	7.49	6.72	13.17	11.38	17.62	18.16	22.97	14.08	15.4	19.21	6.16	4.76	6.05	9.4
EV/EBIT	6.74	11.34	7.18	11.74	10.16	15.54	18.59	20.02	13.29	16.01	10.87	6.45	4.78	16.16	- -
Enterprise Value	185	308	276	355	291	417	737	1,383	1,210	2,148	2,351	1,193	604	47	-39
Low Price	12.97	14.02	21.75	24.04	26.14	27.12	40	61.96	66.5	49.03	184.48	96	61.94	16.7	10.36
EV/Sales	0.62	0.97	0.85	1.24	1.07	1.52	2.44	2.76	1.7	2.3	1.54	0.75	0.56	0.08	- -
EV/EBITDA	5.17	8.66	5.95	9.27	8.14	12.94	16.81	18.81	12.65	15.51	10.54	6.09	4.33	2.98	- -
Price/Earnings	10.33	22.81	15.02	32.25	18.11	27.64	30.03	26.77	16.55	22.47	14.94	8.99	7.36	92.1	- -
Price/Earnings Average	14.71	19.23	14.87	28.82	18.23	22.87	21.8	30.96	17.72	15.05	17.17	12.21	9.8	146.33	-7.94
Price/Earnings High	22.58	28.77	16.94	34.66	20.19	28.65	32.17	55.89	24.08	23.87	24.05	17.31	14.39	368.93	-10.49
Price/Earnings Low	9.77	12.12	12.5	23.11	15.59	18.01	17.21	13.27	10.05	5.61	13.16	7.49	6.78	87.29	-6.09
Price/Book Value	2.9	4	3.48	5.03	4.05	5.15	7.7	13.6	12.3	14.7	11.99	8.09	3.64	0.92	0.59
Price/Book Value Average	4.13	3.37	3.45	4.5	4.07	4.26	5.59	15.73	13.16	9.85	13.78	10.98	4.84	1.46	0.75
Price/Book Value High	6.33	5.05	3.93	5.41	4.51	5.33	8.24	28.39	17.89	15.61	19.29	15.57	7.11	3.67	0.99
Price/Book Value Low	2.74	2.13	2.9	3.61	3.48	3.35	4.41	6.74	7.46	3.67	10.56	6.73	3.35	0.87	0.57
Price/Tangible Book Value	2.94	4.02	3.48	5.03	4.05	5.15	7.7	13.6	12.3	14.7	11.99	8.09	3.64	0.92	0.59
Price/Tangible Book Value Average	4.18	3.39	3.45	4.5	4.07	4.26	5.59	15.73	13.16	9.85	13.78	10.98	4.84	1.46	0.75
Price/Tangible Book Value High	6.42	5.07	3.93	5.41	4.51	5.33	8.24	28.39	17.89	15.61	19.29	15.57	7.11	3.67	0.99
Price/Tangible Book Value Low	2.78	2.14	2.9	3.61	3.48	3.35	4.41	6.74	7.46	3.67	10.56	6.73	3.35	0.87	0.57
Price/Sales	0.64	1.14	1.11	1.49	1.33	1.8	2.76	2.98	1.81	2.47	1.61	0.81	0.68	0.32	0.3
Price/Sales Average	0.91	0.96	1.1	1.33	1.34	1.49	2	3.45	1.93	1.66	1.85	1.1	0.91	0.51	0.38
Price/Sales High	1.4	1.43	1.25	1.6	1.48	1.86	2.96	6.22	2.63	2.63	2.58	1.55	1.33	1.28	0.51
Price/Sales Low	0.61	0.6	0.92	1.07	1.15	1.17	1.58	1.48	1.1	0.62	1.41	0.67	0.63	0.3	0.29
Price/Cash Flow	5.49	8.99	8.5	16.65	12.35	19.45	19.25	24.56	15.31	15.92	25.93	6.64	4.95	7.87	17.09
Price/Cash Flow Average	7.82	7.58	8.41	14.88	12.43	16.09	13.98	28.4	16.39	10.66	29.79	9.01	6.6	12.5	21.6
Price/Cash Flow High	12.01	11.35	9.58	17.89	13.77	20.16	20.62	51.27	22.27	16.91	41.72	12.77	9.69	31.52	28.54
Price/Cash Flow Low	5.19	4.78	7.07	11.93	10.63	12.67	11.03	12.17	9.29	3.97	22.84	5.52	4.57	7.46	16.58
Price/Free Cash Flow Average	5.6	6.32	6.65	11.77	11.45	14.58	13.18	26.56	15.07	10.32	22.07	8.35	6.34	9.61	11.88
Price/Free Cash Flow High	8.59	9.45	7.58	14.15	12.68	18.26	19.45	47.94	20.48	16.36	30.92	11.85	9.31	24.23	15.7
Price/Free Cash Flow Low	3.72	3.98	5.59	9.43	9.79	11.48	10.4	11.38	8.54	3.85	16.93	5.12	4.39	5.73	9.12
EV/Sales Average	0.99	0.85	0.94	1.19	1.17	1.3	1.76	3.26	1.84	1.49	1.78	1.03	0.84	0.38	0.18
EV/Sales High	1.53	1.33	1.08	1.45	1.31	1.67	2.72	6.02	2.54	2.46	2.51	1.47	1.27	1.16	0.3
EV/Sales Low	0.65	0.49	0.77	0.94	0.98	0.98	1.34	1.31	1.01	0.45	1.35	0.61	0.56	0.18	0.09
EV/EBITDA Average	8.24	7.62	6.56	8.88	8.91	11.05	12.13	22.24	13.76	10.08	12.18	8.38	6.47	14.85	2,406.93
EV/EBITDA High	12.78	11.9	7.58	10.8	9.99	14.25	18.71	41.03	18.94	16.63	17.19	12.01	9.75	44.73	4,050.87
EV/EBITDA Low	5.39	4.43	5.39	7.01	7.45	8.35	9.21	8.9	7.52	3.07	9.27	5.02	4.32	6.92	1,215.88
EV/EBIT Average	10.75	9.98	7.91	11.24	11.12	13.27	13.41	23.67	14.46	10.4	12.57	8.88	7.14	80.4	-4.91
EV/EBIT High	16.67	15.58	9.13	13.67	12.47	17.12	20.69	43.67	19.9	17.16	17.74	12.73	10.76	242.25	-8.27
EV/EBIT Low	7.03	5.8	6.5	8.87	9.29	10.03	10.19	9.47	7.9	3.17	9.56	5.31	4.77	37.48	-2.48
Last Price	13.72	26.39	26.13	33.55	30.38	41.63	69.81	125.02	109.58	196.34	209.43	115.35	67.22	17.62	10.68
High Price	29.98	33.29	29.47	36.06	33.86	43.15	74.78	260.98	159.41	208.57	336.99	222	131.42	70.58	17.84
Enterprise Value Average	294	271	304	340	319	356	532	1,634	1,317	1,396	2,718	1,640	903	231	70
Enterprise Value High	456	423	351	413	358	460	820	3,016	1,812	2,303	3,835	2,352	1,360	697	117
Enterprise Value Low	193	157	250	268	267	270	404	654	719	425	2,067	982	602	108	35

Shares Outstanding	16	14	13	12	12	12	12	12	12	12	12	11	11	11	11
Diluted Weighted Avg Shares	14	14	14	13	12	12	12	12	12	12	12	11	11	11	11
Basic Weighted Avg Shares	14	14	14	13	12	12	12	12	12	12	12	11	11	11	11
Revenue per Share	21.35	23.22	23.53	22.52	22.81	23.18	25.29	41.94	60.63	79.42	130.38	142.79	98.5	55.12	35.13
EBITDA per Share	2.56	2.59	3.36	3.02	2.99	2.72	3.68	6.15	8.13	11.76	19.06	17.49	12.82	1.43	- -
Operating Income per Share	1.96	1.98	2.79	2.39	2.4	2.27	3.32	5.78	7.73	11.4	18.47	16.51	11.61	0.26	-1.29
Basic EPS, GAAP	1.33	1.16	1.74	1.04	1.68	1.51	2.32	4.67	6.62	8.74	14.01	12.82	9.13	0.19	-1.7
Basic EPS from Cont Ops	1.33	1.34	1.97	1.66	1.64	1.51	2.32	4.67	6.62	8.74	14.01	12.82	9.13	0.19	-1.7
Diluted EPS, GAAP	1.31	1.16	1.73	1.03	1.66	1.49	2.29	4.62	6.43	8.68	13.89	12.73	9.1	0.19	-1.7
Diluted EPS from Cont Ops	1.31	1.34	1.96	1.65	1.62	1.49	2.29	4.62	6.43	8.68	13.89	12.73	9.1	0.19	-1.7
Dividend per Share	- -	- -	- -	- -	- -	1	1.29	1.94	3.01	4.52	5.46	6.4	6.71	0.07	0.02
Cash Flow per Share	2.5	2.93	3.08	2.02	2.46	2.14	3.63	5.09	7.16	12.34	8.08	17.38	13.57	2.24	0.62
Free Cash Flow per Basic Share	1.45	2.34	2.25	1.46	2.22	1.9	3.35	4.68	6.3	11.83	5.15	15.89	12.97	1.56	0.11
Cash & Equivalents per Share	2.18	4.36	5.17	4.36	5.69	6.47	8.26	8.51	7.88	14.82	9.45	8.07	13.77	14.84	15.22
Book Value per Share	4.73	6.59	7.5	6.66	7.51	8.09	9.07	9.19	8.91	13.36	17.47	14.26	18.49	19.21	18.1
Tangible Book Value per Share	4.67	6.56	7.5	6.66	7.51	8.09	9.07	9.19	8.91	13.36	17.47	14.26	18.49	19.21	18.1

Medifast, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)